Omkar Pharmachem Limited adopted its audited financial statements for the fiscal year ended March 31, 2026, during its 31st Annual General Meeting (AGM) held on September 30, 2026. The meeting also saw the re-appointment of Parminder Sharma as a director and the approval of material related party transactions.

The AGM was chaired by Managing Director Bhawani S Goyal at Hotel Kanak in Ahmedabad. The notice convening the meeting and the auditor's report were taken as read with shareholder consent. Electronic voting facilities were provided to members, with a provision for ballot paper voting for those present who had not cast their votes electronically.

Key resolutions passed

The shareholders transacted both ordinary and special business items outlined in the notice dated August 31, 2026. The following resolutions were approved:

• Adoption of Financial Statements: Receipt and adoption of the audited Balance Sheet, Statement of Profit and Loss, Statement of Change in Equity, and Cash Flow Statement for the year ended March 31, 2026.
• Director Re-appointment: Appointment of Parminder Sharma (DIN: 00176300) in place of himself, who retired by rotation at this meeting and was eligible for re-appointment.
• Related Party Transactions: Approval of material related party transactions as part of special business.

Meeting proceedings and compliance

The meeting commenced at 10:30 am and concluded at 11:00 am with a vote of thanks. Maulik Bhavsar & Associates, a company secretary in practice, was appointed by the Board as the Scrutinizer to supervise the e-voting and ballot voting process. The Chairman declared the results after verifying the quorum and ensuring compliance with the Companies Act, 2013. No voting by show of hands was conducted.

Omkar Pharmachem Ltd reported a net profit of ₹12.18 lakh for FY26, a decline from ₹20.09 lakh in the previous year. Total income for the period ended March 31, 2026, stood at ₹47.24 lakh, down from ₹54.22 lakh in FY25.

The company submitted its 31st Annual General Meeting (AGM) notice and annual report to the Bombay Stock Exchange on September 2, 2026. The AGM is scheduled for September 30, 2026, at Hotel Kanak in Ahmedabad.

Financial Performance

Revenue from operations decreased to ₹46.50 lakh from ₹54.00 lakh in FY25. Employee benefit expenses rose to ₹20.86 lakh from ₹16.07 lakh, while finance costs dropped significantly to ₹0.21 lakh from ₹1.71 lakh due to loan repayment. Other expenses increased slightly to ₹9.56 lakh from ₹8.93 lakh.

Balance Sheet Highlights

Total assets grew to ₹3,669.04 lakh from ₹960.33 lakh, primarily driven by an increase in non-current investments to ₹3,638.43 lakh from ₹930.00 lakh. This revaluation created a Fair Value Through Other Comprehensive Income (FVTOCI) reserve of ₹2,708.43 lakh. The company closed the year with zero borrowings, having repaid its ₹11.85 lakh outstanding debt from FY25. Cash and cash equivalents rose to ₹21.73 lakh from ₹10.94 lakh.

What the Numbers Show

The sharp increase in total assets is not operational but accounting-driven. While operational revenue declined by 15%, total equity surged to ₹3,663.98 lakh from ₹943.37 lakh solely due to the ₹2,708.43 lakh unrealized gain on unlisted equity investments. This masks the underlying operational contraction, where net profit margins fell from 37% to 26% as fixed costs remained elevated despite lower sales volumes.

AGM Agenda and Logistics

The AGM will address three key items:

• Adoption of audited financial statements for FY26.
• Re-appointment of Mr. Parminder Sharma, who retires by rotation.
• Approval of material related-party transactions involving remuneration for Key Managerial Personnel (KMPs), specifically the Company Secretary and CFO, valued up to ₹25 lakh for FY27.

Shareholders holding shares as of the record date, September 23, 2026, are eligible to vote. Remote e-voting via Central Depository Services (India) Limited will be open from September 27 to September 29, 2026.